OTCMKTS:RGUS

REGI U.S. Stock Forecast, Price & News

$0.0072
0.00 (0.00 %)
(As of 09/21/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.01
$0.01
50-Day Range
$0.01
$0.03
52-Week Range
$0.01
$0.06
Volume2,750 shs
Average Volume48,946 shs
Market Capitalization$876,729.60
P/E RatioN/A
Dividend YieldN/A
Beta1.7
30 days | 90 days | 365 days | Advanced Chart
Receive RGUS News and Ratings via Email

Sign-up to receive the latest news and ratings for REGI U.S. and its competitors with MarketBeat's FREE daily newsletter.


About REGI U.S.

REGI U.S., Inc. is a development stage company. It engages in the designing and developing axial vane-type rotary power devices for civilian, commercial, and government applications. Its products include axial vane, rotary engines, compressors, pumps, and gas expanders. The company was founded on July 27, 1992 and is headquartered in Spokane, WA.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











REGI U.S. (OTCMKTS:RGUS) Frequently Asked Questions

What stocks does MarketBeat like better than REGI U.S.?

Wall Street analysts have given REGI U.S. a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but REGI U.S. wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has REGI U.S.'s stock been impacted by Coronavirus?

REGI U.S.'s stock was trading at $0.07 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, RGUS shares have decreased by 89.7% and is now trading at $0.0072.
View which stocks have been most impacted by COVID-19
.

Who are REGI U.S.'s key executives?

REGI U.S.'s management team includes the following people:
  • Paul Willard Chute, Chairman, Chief Executive & Financial Officer
  • Paul L. Porter, President, Director & Chief Technology Officer
  • Michael Urso, Vice President-Operations
  • James Foley, Vice President-Development
  • Lynn L. Petersen, Director & Vice President-Business Development

Who are some of REGI U.S.'s key competitors?

What other stocks do shareholders of REGI U.S. own?

Based on aggregate information from My MarketBeat watchlists, some companies that other REGI U.S. investors own include CannTrust (CNTTF), Corbus Pharmaceuticals (CRBP), Cronos Group (CRON), CannTrust (CTST), Aurora Cannabis (ACB), Aphria (APHA), (CGC), Medmen Enterprises (MMEN), MedMen Enterprises (MMNFF) and Agilysys (AGYS).

What is REGI U.S.'s stock symbol?

REGI U.S. trades on the OTCMKTS under the ticker symbol "RGUS."

How do I buy shares of REGI U.S.?

Shares of RGUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is REGI U.S.'s stock price today?

One share of RGUS stock can currently be purchased for approximately $0.01.

How much money does REGI U.S. make?

REGI U.S. has a market capitalization of $876,729.60 and generates $60,000.00 in revenue each year.

How many employees does REGI U.S. have?

REGI U.S. employs 7 workers across the globe.

What is REGI U.S.'s official website?

The official website for REGI U.S. is www.radmaxtech.com.

Where are REGI U.S.'s headquarters?

REGI U.S. is headquartered at 7520 N. MARKET ST SUITE 10, SPOKANE WA, 99217.

How can I contact REGI U.S.?

REGI U.S.'s mailing address is 7520 N. MARKET ST SUITE 10, SPOKANE WA, 99217. The company can be reached via phone at (509) 474-1040 or via email at [email protected].


This page was last updated on 9/22/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.